Passive immunization and hypothalamic peptide secretion.
Passive immunization is a common approach used to eliminate the biological activity of an endogenous substance by its binding to a specific antibody (Ab). Surprisingly little information has been gathered on the mechanisms involved. Moreover, the possibility that immunoneutralization could affect also the secretion of the antigen itself has been mostly ignored. To study hypothalamic neuropeptide secretion under the condition of passive immunization, labeled and unlabeled monoclonal antibody (MoAb) against arginine vasopressin (AVP) was injected intravenously. After 2 h a similar amount of 125I-MoAb was found in hypophyseal portal and peripheral (femoral artery) plasma, showing a distribution volume of 73.2 ml/kg. Assessment of the MoAb dilution in the same plasma samples from the binding studies revealed substantially higher dilutions (800-5,700 ml/kg). Such a MoAb dilution (saturation) would be attained by the binding of 130-290 pmol AVP/ml plasma. The calculated amount of plasma AVP decreased by one half within the interval from 2 to 24 h after Ab injection, similarly as did the 125I-MoAb content. Intravenous injection of polyclonal corticotropin-releasing hormone (CRH) Ab resulted in a decrease of plasma adrenocorticotropin and corticosterone levels. After 24 h the dilution of the Ab in portal plasma exceeded two times that in peripheral plasma. CRH concentrations of 0.6-2.5 pmol/ml were found by specific radioimmunoassay after its dissociation from the Ab in plasma. The CRH concentration was higher in portal than in peripheral plasma and was related to the amount of the Ab injected. CRH mRNA levels in the paraventricular nucleus were significantly increased in CRH Ab as compared with normal rabbit serum injected rats.(ABSTRACT TRUNCATED AT 250 WORDS)
Strbák
V
V
Institute of Experimental Endocrinology SAS, Bratislava, Slovak Republic.
Guillaume
V
V
Grino
M
M
Dutour
A
A
Burlet
A J
AJ
Oliver
C
C
D000818:Animals; D000911:Antibodies, Monoclonal; D000918:Antibody Specificity; D001127:Arginine Vasopressin / Q000276:immunology*; D003346:Corticotropin-Releasing Hormone / Q000097:blood / Q000276:immunology*; D005263:Femoral Artery / Q000276:immunology; D007031:Hypothalamus / Q000276:immunology / Q000378:metabolism*; D007116:Immunization, Passive; D008297:Male; D009479:Neuropeptides / Q000276:immunology / Q000378:metabolism*; D010902:Pituitary Gland / Q000098:blood supply; D011168:Portal System / Q000276:immunology; D051381:Rats; D017207:Rats, Sprague-Dawley
D000911:Antibodies, Monoclonal; D009479:Neuropeptides; D001127:Arginine Vasopressin; D003346:Corticotropin-Releasing Hormone